
Kies je etiket
direct zichtbaar op de vialMazdutide
GLP-1
- Verzonden vanuit Duitsland
Bestelling
- DHL met tracking
- Discrete verpakking
4.6 van 5 op Trustpilot73 reviews
Ook gezocht als: Mazdutid · LY3305677 · IBI362
In één oogopslag
Mazdutide in cijfers
De kerncijfers uit ons lexicon.
Volledig lexiconartikel- Class
- GLP-1 / glucagon dual agonistoxyntomodulin analogue
- Half-life
- Several daysweekly dose
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
All 6 sources in the lexiconMeta-analysis of efficacy and safety (diabetics and non-diabetics) (opens in a new tab)
Frontiers in Endocrinology, 2024Phase 3 trial GLORY-1 in overweight and obesity in China (610 adults, 48 weeks) (opens in a new tab)
Ji et al., New England Journal of Medicine, 2025Phase 2 trial in the USA up to the highest study dose (48 weeks) (opens in a new tab)
Hsia et al., The Lancet Diabetes & Endocrinology, 2026
Er is nog geen labanalyse voor Mazdutide. Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses
Kennis
Alles over Mazdutide
Uitgebreide informatie volgt binnenkort.
Dosering
Doseringsinformatie laden …
Handig om erbij te hebben
Wat je erbij nodig hebt
Bacteriostatisch water wordt automatisch aan je winkelwagen toegevoegd. Spuiten en doekjes met één klik.
Insulinespuiten
10 stuks · 5.50 €
Alcoholdoekjes
50 stuks · 10 €
Hoeveel water?
Eenheden op de spuit voor jouw vialgrootte.
Naar de calculator →Is Mazdutide approved?
In China, yes. The first approval came in June 2025 for long-term weight management in obesity or overweight with a related condition, type 2 diabetes followed in September 2025. Mazdutide is not approved in the EU or the USA, ChEMBL lists phase 3 as the highest phase. The information here describes the state of research and is not a recommendation for use.
How does Mazdutide differ from Tirzepatide and Retatrutide?
The receptors. Mazdutide acts on GLP-1 and glucagon, Tirzepatide on GLP-1 and GIP, Retatrutide on all three. Mazdutide is derived from the gut hormone oxyntomodulin, which naturally addresses both receptors. A running trial with a higher dose compares it directly with Tirzepatide, there are no results yet.
What did the phase 3 trials show?
In GLORY-1 weight fell by 11.0 and 14.0 percent on average after 48 weeks, on placebo it rose by 0.3 percent. In GLORY-2 with a higher dose it was 16.7 versus 1.5 percent after 60 weeks. In type 2 diabetes HbA1c fell by 1.57 and 2.15 percentage points after 24 weeks (placebo 0.14). Against dulaglutide both doses were ahead for HbA1c and weight.
How long does Mazdutide stay in the body?
In the first phase 1b study in China the half-life was between 6.3 and 16.8 days. An attached fatty acid makes this possible. That fits one dose a week, which is how all trials give Mazdutide.
How high were the doses in trials?
The highest study dose was 16 mg per week, in a phase 1 study and a phase 2 trial in the USA. There weight fell by 18.1 percent after 32 weeks, but 20 percent stopped because of side effects. All trials raise the dose in steps over weeks. The entry describes the same principle: start low and only increase while there is no noticeable effect. This is not a dosing recommendation.
Which side effects were seen?
Mainly gastrointestinal effects, mostly mild to moderate. In GLORY-2 53.1 percent had vomiting, 46.9 percent nausea and 39.4 percent diarrhoea (placebo 1.3, 3.2 and 6.5 percent). In GLORY-1 only 0.5 to 1.5 percent stopped because of side effects. In an early study the complaints occurred mainly in the first dose levels.
Which trials are still running?
Four of the listed phase 3 trials are not finished yet: on fatty liver versus semaglutide, on sleep apnoea, in adolescents and on high blood pressure. Phase 2 trials are running on heart failure with obesity and on fatty liver with inflammation (MASH).
Gerelateerd
Gerelateerde producten
Tirzepatide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
10 maten
Laboratoriumgetest
= vanaf 10 €/vial
Retatrutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
11 maten
Laboratoriumgetest
= vanaf 16 €/vial
Semaglutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
6 maten
Laboratoriumgetest
= vanaf 10 €/vial
Survodutide
Peptiden · GLP-1 & vetverlies GLP-1 & vetverlies
1 maat
= 60.8 €/vial
Mazdutide